The Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences provides national and international recognition and support to those at the forefront of cardiovascular sciences.

The recipient will be a leader in cardiovascular sciences, a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care.

The Schottenstein Laureate will also receive an honorarium of $100,000 (US).

Established by a $2 million endowment from humanitarian philanthropists Jay and Jeanie Schottenstein, the prize is chartered to The Ohio State University Wexner Medical Center’s Heart and Vascular Center, and will be awarded biennially.

2021 Schottenstein Prize Nomination Period Has Closed

2019 Schottenstein Prize Laureate

HTVADEV_18109307_SchottPrizePhoto_644x500

Dan Roden, MD

A native of Montreal, Canada, Dr. Roden received his medical degree and trained in Internal Medicine at McGill University. He began his career at Vanderbilt University School of Medicine where he remains today, servings as Professor of Medicine, Pharmacology and Biomedical Informatics and as Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center. His research program studies how genetic variation affects human disease susceptibility, with a focus in cardiac rhythm abnormalities, and responses to drugs, also known as pharmocogenetics. After serving as chief of the division of Clinical Pharmacology for 12 years, he was tasked in 2006 with leading Vanderbilt’s efforts in Personalized Medicine. Under his leadership, Vanderbilt has become internationally-recognized for cutting edge programs in this area, including the large (250,000 sample) biobank BioVU and the EHR-based preemptive pharmacogenetic program PREDICT.  He has been Principal Investigator for the Vanderbilt sites of the Pharmacogenomics Research Network since 2001 and of the Electronic Medical Records and Genomics (eMERGE) Network since 2007.

Past Winners of the Schottenstein Prize

Helen Hobbs

Helen Hobbs, MD

2017 Prize Laureate

Helen Hobbs, MD, is a Professor of Internal Medicine and Molecular Genetics  at UT Southwestern Medical Center. She is co-director of the Hobbs-Cohen Lab in the Eugene McDermott Center for Human Growth and Development  Since 2002 she has been a Howard Hughes Investigator. Dr. Hobbs was elected to the Institute of Medicine in 2004 and the National Academy of Sciences in 2007. She was awarded the Breakthrough Prize in Life Sciences in 2015 and the Passano Award (with Jonathan Cohen) in 2016. She holds the Philip O'Bryan Montgomery Jr., M.D., Distinguished Chair in Developmental Biology and Eugene McDermott Distinguished Chair for the Study of Human Growth and Development.
Dr_Bolli

Roberto Bolli, MD, FAHA

2015 Prize Laureate

Dr. Roberto Bolli is Professor of Medicine, Physiology and Biophysics; Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology; Executive Vice Chair, Department of Medicine; Director, Institute of Molecular Cardiology and Distinguished University Scholar at the University of Louisville School of Medicine.

GarretFitzgerald

Garret FitzGerald, MD

2013 Prize Laureate

Dr. Garret FitzGerald is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics.

SeidmanChristine

Christine Seidman, MD

2011 Prize Laureate

Christine Seidman, MD is Professor, Departments of Medicine and Genetics at Harvard Medical School and Brigham and Women’s Hospital, where she is also the Thomas W. Smith Professor of Medicine.

GoldschmidtPascal

Pascal Goldschmidt, MD

2009 Prize Laureate

Pascal Goldschmidt, MD, was the inaugural recipient of the Schottenstein Prize. He is a cardiologist and cardiovascular researcher, and former dean of the University of Miami Leonard M. Miller School of Medicine. Until January 2016 he also served as chief executive officer of the University of Miami Health System (UHealth). He is currently President and CEO of American Healthcare System, European Care Global & Alzady International. 

Schottenstein Prize in Cardiovascular Sciences

SchottensteinPrizeInCardiovascularScience

Eligibility and Award Details

This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care.

Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery.

The prize is awarded biennially.

The 2021 nomination period has closed. An announcement of the 2021 Schottenstein Prize laureate will be forthcoming later this year.

Jay and Jeanie Schottensteins

About Jay and Jeanie Schottenstein

In 2008, Jay and Jeanie Schottenstein endowed $2 million to The Ohio State University Wexner Medical Center to create the Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences. As Ohio natives, Jay and Jeanie provided the prize to further establish Ohio State as a leader in cardiovascular care at a global level.

With an extensive record of charitable giving to local, national and international causes, the Schottensteins ensure decades of cardiovascular excellence at Ohio State with this prize that honors those who have made extraordinary contributions to improving the field of heart and vascular research and patient care.

Read more

Share this Page